LLY - Lilly weight loss drug tirzepatide meets primary endpoint in sleep apnea study
2024-06-21 16:24:19 ET
More on Eli Lilly
- Eli Lilly: The Party Is Probably Nearing The End
- Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Hims & Hers defended at BofA as Lilly fights compounded GLP-1s
- Eli Lilly ramps up efforts against fake weight loss drugs